Evaluation of Gut Microbiota and Its Associated Resistome in FMT Donors and Recipients Due to Rec… (NCT06533800) | Clinical Trial Compass
Not Yet RecruitingNot Applicable
Evaluation of Gut Microbiota and Its Associated Resistome in FMT Donors and Recipients Due to Recurrent Clostridiodes Difficile Infection
24 participantsStarted 2024-09-15
Plain-language summary
Caratterizzazione della composizione microbica intestinale nei donatori di FMT e nei pazienti affetti da rCDI al tempo basale e a seguito del trapianto di microbiota fecale. Negli stessi time point valutare il resistoma associato alla comunità microbica rilevata.
Who can participate
Age range18 Years
SexALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion criteria
* patients with rCDI (\> 18 years) to whom faecal microbiota transplantation is indicated, without other pathologies or prolonged hospitalization periods
* donors: healthy volunteers aged between 18 and 50 years
* Patients capable of expressing consent
Exclusion criteria
* antibiotic therapies in the last 30 days
* treatments with prebiotics - probiotics - postbiotics in the last 60 days
* colonization by MDR or XDR pathogens
* presence of pre-existing or ongoing intestinal pathologies (Inflammatory Intestinal Diseases, chronic hepatitis, celiac disease, neoplasms, previous large intestinal resections)
* ongoing diarrhea of any origin (defined as more than 6 watery stools per day and/or faecal volume greater than 250 ml in 24 hours)
* severe septic state in progress
* for donors: drug addiction, promiscuous sexual behaviour, use of drugs that can be excreted in the faeces with potential risk for recipients
What they're measuring
1
Assessment of gut microbiota e associated resitome